HCQ01
HYDR0121/CCO
Phase 2 small_molecule active
Quick answer
HCQ01 for 2019 Novel Coronavirus is a Phase 2 program (small_molecule) at Sana Biotechnology with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Sana Biotechnology
- Indication
- 2019 Novel Coronavirus
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active